0
     

Report Added
Report already added
North America Single Cell Multiomics Market 2021-2031 by Product Type (Instruments, Consumables, Software), Omics Type (SCG, SCT, SCP, SCM), Application (Clinical Research, Translation Research, Synthetic Biology), Sample Type (Human, Animal, Microbial), Workflow (Single-Cell Isolation and Dispensing, Single-Cell Analysis), End User (Research and Academic Laboratories, Biopharma and Biotech Companies, CROs, Others), and Country: Trend Forecast and Growth Opportunity

North America Single Cell Multiomics Market 2021-2031 by Product Type (Instruments, Consumables, Software), Omics Type (SCG, SCT, SCP, SCM), Application (Clinical Research, Translation Research, Synthetic Biology), Sample Type (Human, Animal, Microbial), Workflow (Single-Cell Isolation and Dispensing, Single-Cell Analysis), End User (Research and Academic Laboratories, Biopharma and Biotech Companies, CROs, Others), and Country: Trend Forecast and Growth Opportunity

North America single cell multiomics market is projected to grow by 17.6% annually in the forecast period and reach $ 6,153.0 million by 2031, driven by the rising prevalence of chronic diseases along with the aging population, the widespread product adoption for visualization and analysis, technological advancements along with the rising R&D investment, and the significant growth in the pharmaceutical industry especially personalized medication.
Highlighted with 29 tables and 73 figures, this 143-page report “North America Single Cell Multiomics Market 2021-2031 by Product Type (Instruments, Consumables, Software), Omics Type (SCG, SCT, SCP, SCM), Application (Clinical Research, Translation Research, Synthetic Biology), Sample Type (Human, Animal, Microbial), Workflow (Single-Cell Isolation and Dispensing, Single-Cell Analysis), End User (Research and Academic Laboratories, Biopharma and Biotech Companies, CROs, Others), and Country: Trend Forecast and Growth Opportunity” is based on a comprehensive research of the entire North America single cell multiomics market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2019-2021 and provides forecast from 2022 till 2031 with 2021 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)

In-depth qualitative analyses include identification and investigation of the following aspects:
•Market Structure
•Growth Drivers
•Restraints and Challenges
•Emerging Product Trends & Market Opportunities
•Porter’s Fiver Forces
The trend and outlook of North America market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19 and Russia-Ukraine conflict. The balanced (most likely) projection is used to quantify North America single cell multiomics market in every aspect of the classification from perspectives of Product Type, Omics Type, Application, Sample Type, Workflow, End User, and Country.

Based on Product Type, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
•Instruments
•Consumables
•Software

Based on Omics Type, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
•Single Cell Genomics (SCG)
•Single Cell Transcriptomics (SCT)
•Single Cell Proteomics (SCP)
•Single Cell Metabolomics (SCM)

By Application, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
•Clinical Research
oOncology
oCell Therapy
oImmunology
oNeurology
oCell Biology
oOther Types of Clinical Research
•Translation Research
•Synthetic Biology

By Sample Type, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
•Human Samples
oCancer Tissues
oStem Cells
oImmune Cells
oBrain Cells
oOther Human Samples
•Animal Samples
•Microbial Samples

By Workflow, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
•Single-Cell Isolation and Dispensing
oFluorescence-Activated Cell Sorting (FACS)
oMicrofluidics
oMagnetic-Activated Cell Sorting (MACS)
oRandom Seeding
oManual Cell Picking
oLaser Capture Microdissection
oOther Technologies of Single-Cell Isolation and Dispensing
•Single-Cell Analysis
oPolymerase Chain Reaction
oNext-Generation Sequencing
oMass Cytometry
oMass Spectrometry
oOther Technologies of Single-Cell Analysis

By End User, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
•Research and Academic Laboratories
•Biopharmaceutical and Biotech Companies
•Contract Research Organizations (CROs)
•Other End Users

Geographically, the following national/local markets are fully investigated:
•U.S.
•Canada
•Mexico
For each key country, detailed analysis and data for annual revenue ($ mn) are available for 2021-2031. The breakdown of national markets by Omics Type, Workflow and End User over the forecast years are also included.

The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.

Selected Key Players:
10x Genomics, Inc.
1CellBio, Inc.
Becton, Dickinson and Company
Berkeley Lights, Inc.
BGI Genomics Co., Ltd.
Bio-Rad Laboratories, Inc.
Bio-Techne Corporation
BioTuring, Inc.
Danaher Corporation (Cytiva Life Sciences)
Dolomite Bio
Fluidigm Corporation
Fluxion Biosciences
Illimina, Inc
Mission Bio, Inc.
Namocell, Inc.
NanoString Technologies, Inc.
Parse Biosciences, Inc.
Proteona
Qiagen N.V.
RareCyte, Inc.
Scipio Biosciences SAS
Shilps Sciences
Takara Bio Inc. (Takara Holdings)
Thermo Fisher Scientific Inc.
(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
Table of Contents

1 Introduction8
1.1 Industry Definition and Research Scope8
1.1.1 Industry Definition8
1.1.2 Research Scope9
1.2 Research Methodology12
1.2.1 Overview of Market Research Methodology12
1.2.2 Market Assumption13
1.2.3 Secondary Data13
1.2.4 Primary Data13
1.2.5 Data Filtration and Model Design14
1.2.6 Market Size/Share Estimation15
1.2.7 Research Limitations16
1.3 Executive Summary17
2 Market Overview and Dynamics20
2.1 Market Size and Forecast20
2.1.1 Impact of COVID-19 on World Economy21
2.1.2 Impact of COVID-19 on the Market25
2.2 Major Growth Drivers27
2.3 Market Restraints and Challenges35
2.4 Emerging Opportunities and Market Trends38
2.5 Porter’s Fiver Forces Analysis42
3 Segmentation of North America Market by Product Type46
3.1 Market Overview by Product Type46
3.2 Instruments48
3.3 Consumables49
3.4 Software50
4 Segmentation of North America Market by Omics Type51
4.1 Market Overview by Omics Type51
4.2 Single Cell Genomics (SCG)53
4.3 Single Cell Transcriptomics (SCT)54
4.4 Single Cell Proteomics (SCP)55
4.5 Single Cell Metabolomics (SCM)56
5 Segmentation of North America Market by Application57
5.1 Market Overview by Application57
5.2 Clinical Research59
5.2.1 Oncology61
5.2.2 Cell Therapy62
5.2.3 Immunology63
5.2.4 Neurology64
5.2.5 Cell Biology65
5.2.6 Other Types of Clinical Research66
5.3 Translation Research67
5.4 Synthetic Biology68
6 Segmentation of North America Market by Sample Type69
6.1 Market Overview by Sample Type69
6.2 Human Samples71
6.2.1 Cancer Tissues73
6.2.2 Stem Cells74
6.2.3 Immune Cells75
6.2.4 Brain Cells76
6.2.5 Other Human Samples77
6.3 Animal Samples78
6.4 Microbial Samples79
7 Segmentation of North America Market by Workflow80
7.1 Market Overview by Workflow80
7.2 Single-Cell Isolation and Dispensing82
7.2.1 Fluorescence-Activated Cell Sorting (FACS)84
7.2.2 Microfluidics85
7.2.3 Magnetic-Activated Cell Sorting (MACS)86
7.2.4 Random Seeding87
7.2.5 Manual Cell Picking88
7.2.6 Laser Capture Microdissection89
7.2.7 Other Technologies of Single-Cell Isolation and Dispensing90
7.3 Single-Cell Analysis91
7.3.1 Polymerase Chain Reaction93
7.3.2 Next-Generation Sequencing94
7.3.3 Mass Cytometry95
7.3.4 Mass Spectrometry96
7.3.5 Other Technologies of Single-Cell Analysis97
8 Segmentation of North America Market by End User98
8.1 Market Overview by End User98
8.2 Research and Academic Laboratories100
8.3 Biopharmaceutical and Biotech Companies101
8.4 Contract Research Organizations (CROs)102
8.5 Other End Users103
9 North America Market 2021-2031 by Country104
9.1 Overview of North America Market104
9.2 U.S.107
9.3 Canada110
9.4 Mexico112
10 Competitive Landscape114
10.1 Overview of Key Vendors114
10.2 New Product Launch, Partnership, Investment, and M&A117
10.3 Company Profiles118
10x Genomics, Inc.118
1CellBio, Inc.120
Becton, Dickinson and Company121
Berkeley Lights, Inc.122
BGI Genomics Co., Ltd.123
Bio-Rad Laboratories, Inc.124
Bio-Techne Corporation125
BioTuring, Inc.126
Danaher Corporation (Cytiva Life Sciences)127
Dolomite Bio128
Fluidigm Corporation129
Fluxion Biosciences130
Illimina, Inc131
Mission Bio, Inc.132
Namocell, Inc.133
NanoString Technologies, Inc.134
Parse Biosciences, Inc.135
Proteona136
Qiagen N.V.137
RareCyte, Inc.138
Scipio Biosciences SAS139
Shilps Sciences140
Takara Bio Inc. (Takara Holdings)141
Thermo Fisher Scientific Inc.142
RELATED REPORTS143

List of Figures:

Figure 1. Research Method Flow Chart12
Figure 2. Bottom-up Approach and Top-down Approach for Market Estimation15
Figure 3. North America Market Forecast in Optimistic, Conservative and Balanced Perspectives, 2021-203117
Figure 4. North America Single Cell Multiomics Market, 2021-2031, $ mn20
Figure 5. Impact of COVID-19 on Business25
Figure 6. Primary Drivers and Impact Factors of North America Single Cell Multiomics Market27
Figure 7. Leading Causes of Death in the World, 2000 and 2019, million30
Figure 8. Total Reported Cases of Lyme Disease by Year in U.S., 1998-201931
Figure 9. Worldwide Geriatric Population (60 years and above) by Regions, 2015 & 2030, million33
Figure 10. World Population 65 and Over, % of Total Population, 1950-206033
Figure 11. Primary Restraints and Impact Factors of North America Single Cell Multiomics Market35
Figure 12. Investment Opportunity Analysis39
Figure 13. Porter’s Fiver Forces Analysis of North America Single Cell Multiomics Market42
Figure 14. Breakdown of North America Single Cell Multiomics Market by Product Type, 2021-2031, % of Revenue47
Figure 15. North America Addressable Market Cap in 2022-2031 by Product Type, Value ($ mn) and Share (%)47
Figure 16. North America Single Cell Multiomics Market by Product Type: Instruments, 2021-2031, $ mn48
Figure 17. North America Single Cell Multiomics Market by Product Type: Consumables, 2021-2031, $ mn49
Figure 18. North America Single Cell Multiomics Market by Product Type: Software, 2021-2031, $ mn50
Figure 19. Breakdown of North America Single Cell Multiomics Market by Omics Type, 2021-2031, % of Sales Revenue52
Figure 20. North America Addressable Market Cap in 2022-2031 by Omics Type, Value ($ mn) and Share (%)52
Figure 21. North America Single Cell Multiomics Market by Omics Type: Single Cell Genomics (SCG), 2021-2031, $ mn53
Figure 22. North America Single Cell Multiomics Market by Omics Type: Single Cell Transcriptomics (SCT), 2021-2031, $ mn54
Figure 23. North America Single Cell Multiomics Market by Omics Type: Single Cell Proteomics (SCP), 2021-2031, $ mn55
Figure 24. North America Single Cell Multiomics Market by Omics Type: Single Cell Metabolomics (SCM), 2021-2031, $ mn56
Figure 25. Breakdown of North America Single Cell Multiomics Market by Application, 2021-2031, % of Sales Revenue58
Figure 26. North America Addressable Market Cap in 2022-2031 by Application, Value ($ mn) and Share (%)58
Figure 27. North America Single Cell Multiomics Market by Application: Clinical Research, 2021-2031, $ mn59
Figure 28. North America Single Cell Multiomics Market by Clinical Research: Oncology, 2021-2031, $ mn61
Figure 29. North America Single Cell Multiomics Market by Clinical Research: Cell Therapy, 2021-2031, $ mn62
Figure 30. North America Single Cell Multiomics Market by Clinical Research: Immunology, 2021-2031, $ mn63
Figure 31. North America Single Cell Multiomics Market by Clinical Research: Neurology, 2021-2031, $ mn64
Figure 32. North America Single Cell Multiomics Market by Clinical Research: Cell Biology, 2021-2031, $ mn65
Figure 33. North America Single Cell Multiomics Market by Clinical Research: Other Types of Clinical Research, 2021-2031, $ mn66
Figure 34. North America Single Cell Multiomics Market by Application: Translation Research, 2021-2031, $ mn67
Figure 35. North America Single Cell Multiomics Market by Application: Synthetic Biology, 2021-2031, $ mn68
Figure 36. Breakdown of North America Single Cell Multiomics Market by Sample Type, 2021-2031, % of Revenue70
Figure 37. North America Addressable Market Cap in 2022-2031 by Sample Type, Value ($ mn) and Share (%)70
Figure 38. North America Single Cell Multiomics Market by Sample Type: Human Samples, 2021-2031, $ mn71
Figure 39. North America Single Cell Multiomics Market by Human Samples: Cancer Tissues, 2021-2031, $ mn73
Figure 40. North America Single Cell Multiomics Market by Human Samples: Stem Cells, 2021-2031, $ mn74
Figure 41. North America Single Cell Multiomics Market by Human Samples: Immune Cells, 2021-2031, $ mn75
Figure 42. North America Single Cell Multiomics Market by Human Samples: Brain Cells, 2021-2031, $ mn76
Figure 43. North America Single Cell Multiomics Market by Human Samples: Other Human Samples, 2021-2031, $ mn77
Figure 44. North America Single Cell Multiomics Market by Sample Type: Animal Samples, 2021-2031, $ mn78
Figure 45. North America Single Cell Multiomics Market by Sample Type: Microbial Samples, 2021-2031, $ mn79
Figure 46. Breakdown of North America Single Cell Multiomics Market by Workflow, 2021-2031, % of Revenue81
Figure 47. North America Addressable Market Cap in 2022-2031 by Workflow, Value ($ mn) and Share (%)81
Figure 48. North America Single Cell Multiomics Market by Workflow: Single-Cell Isolation and Dispensing, 2021-2031, $ mn82
Figure 49. North America Single Cell Multiomics Market by Single-Cell Isolation and Dispensing: Fluorescence-Activated Cell Sorting (FACS), 2021-2031, $ mn84
Figure 50. North America Single Cell Multiomics Market by Single-Cell Isolation and Dispensing: Microfluidics, 2021-2031, $ mn85
Figure 51. North America Single Cell Multiomics Market by Single-Cell Isolation and Dispensing: Magnetic-Activated Cell Sorting (MACS), 2021-2031, $ mn86
Figure 52. North America Single Cell Multiomics Market by Single-Cell Isolation and Dispensing: Random Seeding, 2021-2031, $ mn87
Figure 53. North America Single Cell Multiomics Market by Single-Cell Isolation and Dispensing: Manual Cell Picking, 2021-2031, $ mn88
Figure 54. North America Single Cell Multiomics Market by Single-Cell Isolation and Dispensing: Laser Capture Microdissection, 2021-2031, $ mn89
Figure 55. North America Single Cell Multiomics Market by Single-Cell Isolation and Dispensing: Other Technologies of Single-Cell Isolation and Dispensing, 2021-2031, $ mn90
Figure 56. North America Single Cell Multiomics Market by Workflow: Single-Cell Analysis, 2021-2031, $ mn91
Figure 57. North America Single Cell Multiomics Market by Single-Cell Analysis: Polymerase Chain Reaction, 2021-2031, $ mn93
Figure 58. North America Single Cell Multiomics Market by Single-Cell Analysis: Next-Generation Sequencing, 2021-2031, $ mn94
Figure 59. North America Single Cell Multiomics Market by Single-Cell Analysis: Mass Cytometry, 2021-2031, $ mn95
Figure 60. North America Single Cell Multiomics Market by Single-Cell Analysis: Mass Spectrometry, 2021-2031, $ mn96
Figure 61. North America Single Cell Multiomics Market by Single-Cell Analysis: Other Technologies of Single-Cell Analysis, 2021-2031, $ mn97
Figure 62. Breakdown of North America Single Cell Multiomics Market by End User, 2021-2031, % of Revenue98
Figure 63. North America Addressable Market Cap in 2022-2031 by End User, Value ($ mn) and Share (%)99
Figure 64. North America Single Cell Multiomics Market by End User: Research and Academic Laboratories, 2021-2031, $ mn100
Figure 65. North America Single Cell Multiomics Market by End User: Biopharmaceutical and Biotech Companies, 2021-2031, $ mn101
Figure 66. North America Single Cell Multiomics Market by End User: Contract Research Organizations (CROs), 2021-2031, $ mn102
Figure 67. North America Single Cell Multiomics Market by End User: Other End Users, 2021-2031, $ mn103
Figure 68. Breakdown of North America Single Cell Multiomics Market by Country, 2021 and 2031, % of Revenue105
Figure 69. Contribution to North America 2022-2031 Cumulative Market by Country, Value ($ mn) and Share (%)106
Figure 70. U.S. Single Cell Multiomics Market, 2021-2031, $ mn108
Figure 71. Canada Single Cell Multiomics Market, 2021-2031, $ mn110
Figure 72. Single Cell Multiomics Market in Mexico, 2021-2031, $ mn112
Figure 73. Growth Stage of North America Single Cell Multiomics Industry over the Forecast Period114

Report Title: North America Single Cell Multiomics Market 2021-2031 by Product Type (Instruments, Consumables, Software), Omics Type (SCG, SCT, SCP, SCM), Application (Clinical Research, Translation Research, Synthetic Biology), Sample Type (Human, Animal, Microbial), Workflow (Single-Cell Isolation and Dispensing, Single-Cell Analysis), End User (Research and Academic Laboratories, Biopharma and Biotech Companies, CROs, Others), and Country: Trend Forecast and Growth Opportunity


Your Details
Valid Invalid number

SELECT A FORMAT

ADD TO CART BUY NOW